CPDA-1 1.84 g/70mL (Anticoagulant Citrate Phosphate Dextrose Adenine SOLUTION) 1.84 g/70mL

CPDA-1 1.84 g/70mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine, aiding in blood storage and compatibility. Ideal for medical facilities requiring reliable anticoagulant solutions.

Strength

1.84 g/70mL

Pack Size

70 mL in 1 BAG (0942-6326-04)

Manufacturer / TM Owner

Fenwal, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CPDA-1 1.84 g/70mL is primarily used to preserve blood components during storage. This anticoagulant solution helps maintain the quality and viability of blood for transfusions. It is commonly used in hospitals and blood banks to ensure the safety and effectiveness of stored blood products. What is CPDA-1 used for? It is designed to prevent clotting and support the preservation of red blood cells and other blood components.

Side Effects

The effects of CPDA-1 1.84 g/70mL include preventing blood clotting and maintaining the integrity of blood components. This solution helps extend the shelf life of stored blood, ensuring it remains viable for transfusion. Users may notice improved blood preservation and reduced clotting risks when using this solution.

Precautions & Warnings

Handle CPDA-1 1.84 g/70mL with care, ensuring it is stored and administered according to medical guidelines. Check for any signs of contamination or damage before use. Always follow proper procedures for intravenous administration to minimize risks. Consult healthcare professionals for specific handling instructions.

Avoid Interactions

CPDA-1 1.84 g/70mL may interact with certain medications or substances. It is important to consider potential interactions with other anticoagulants or blood-thinning agents. Always consult a healthcare provider before combining this solution with other treatments to ensure safety and effectiveness.

Frequently Asked Questions

CPDA-1 is used to preserve blood components during storage, preventing clotting and maintaining the viability of blood for transfusions.

CPDA-1 should be stored according to medical guidelines, typically in a cool, dry place away from direct sunlight.

Consult a healthcare provider before combining CPDA-1 with other anticoagulants to ensure safety and effectiveness.

CPDA-1 contains citrate, phosphate, dextrose, and adenine, which work together to preserve blood components.

CPDA-1 is designed to be compatible with various blood types, but specific compatibility should be confirmed with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.